Prosecution Insights
Last updated: August 06, 2026
Application No. 17/998,436

QUINAZOLINE COMPOUNDS AS INHIBITORS OF PREMATURE TERMINATION CODONS

Final Rejection
Filed
Nov 10, 2022
Priority
May 12, 2020 — EU 20305478.8 +1 more
Examiner
KIFLE, BRUCK
Art Unit
1624
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Association Institut De Myologie
OA Round
3 (Final)
79%
Grant Probability
Favorable
4-5
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
1373 granted / 1733 resolved
+19.2% vs TC avg
Strong +16% interview lift
Without
With
+15.9%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 10m
Avg Prosecution
42 currently pending
Career history
1751
Total Applications
across all art units

Statute-Specific Performance

§101
6.0%
-34.0% vs TC avg
§103
12.6%
-27.4% vs TC avg
§102
12.2%
-27.8% vs TC avg
§112
53.9%
+13.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1733 resolved cases

Prosecution Timeline

Nov 10, 2022
Application Filed
Sep 04, 2025
Non-Final Rejection mailed
Dec 02, 2025
Response Filed
Mar 09, 2026
Final Rejection mailed
Jun 03, 2026
Request for Continued Examination
Jun 08, 2026
Response after Non-Final Action
Jun 25, 2026
Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12692240
METHOD FOR PREPARING 3,6-DIAMINOPYRAZINE-2,5-DICARBOXYLIC ACID AND SYNTHETIC INTERMEDIATE THEREOF
3y 2m to grant Granted Jul 28, 2026
Patent 12691097
METHODS AND COMPOSITIONS FOR TREATING POLYOMAVIRUS
3y 0m to grant Granted Jul 28, 2026
Patent 12692229
MASP-2 INHIBITORS AND METHODS OF USE
2y 1m to grant Granted Jul 28, 2026
Patent 12678505
LEAKAGE INHIBITING AGENT FOR LOCAL INJECTION PREPARATION, LOCAL INJECTION PREPARATION INCLUDING THE SAME, AND METHOD FOR PRODUCING LOCAL INJECTION PREPARATION
2y 5m to grant Granted Jul 14, 2026
Patent 12673945
3-((8-((1H-PYRAZOL-4-YL)AMINO)IMIDAZO[1,2-A]PYRIDIN-3-YL)ETHINYL)-N-PHENYLBENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER
3y 10m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

4-5
Expected OA Rounds
79%
Grant Probability
95%
With Interview (+15.9%)
1y 10m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1733 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month